COVID-19 prophylaxis with immunoglobulin Y (IgY) for the world population: The critical role that governments and non-governmental organizations can play.

Frumkin, Lyn R; Lucas, Michaela; Wallach, Michael; Scribner, Curtis L; St John, Tom; Mochly-Rosen, Daria

Frumkin, Lyn R; Lucas, Michaela; Wallach, Michael; Scribner, Curtis L; St John, Tom; Mochly-Rosen, Daria.

Afiliación

Frumkin LR; SPARK at Stanford, Stanford University, School of Medicine, Stanford, California, USA.
Lucas M; Medical School, The University of Western Australia, Perth, Western Australia, Australia.
Wallach M; University of Technology Sydney, Sydney, New South Wales, Australia.
Scribner CL; SPARK Sydney, Sydney, New South Wales, Australia.
St John T; Independent Regulatory Consultant, Oakland, California, USA.
Mochly-Rosen D; SPARK at Stanford, Stanford University, School of Medicine, Stanford, California, USA.

J Glob Health ; 12: 03080, 2022 12 03.

Article en En | MEDLINE | ID: mdl-36462205

Asunto(s)

COVID-19; Humanos; COVID-19/prevención & control; Gobierno; Inmunoglobulinas

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: COVID-19 Límite: Humans Idioma: En Revista: J Glob Health Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google